News

Weight Loss, Drugs and Beats Ozempic

Surgery Still Beats Ozempic and Other GLP-1 Drugs in Real-World Weight Loss Study
Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.
Beyond Ozempic: New weight loss drug rivals surgery
Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that targets four gut hormones instead of the usual one to three. These next-gen tetra-functional peptides may overcome the limitations of current drugs like Ozempic and Mounjaro especially their nausea,
Chemists design a next generation of weight-loss drugs
Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population. Despite their effectiveness, they have drawbacks. Their effect may not last after discontinuing use,
Weight-loss drugs were said to be a game changer. Turns out the benefit might be thinner than thought
Lastly, the researchers observed that while patients who discontinued obesity medications lost significantly less weight compared to those who did not, their weight trajectories remained relatively stable. They said that would be the subject of additional research.
The whole truth about weight-loss drugs
(In the weekly Health Matters newsletter, Ramya Kannan writes about getting to good health, and staying there. You can subscribe here to get the newsletter in your inbox.)
Weight-Loss Drugs Show Promise but Remain Hard to Access
Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is holding back their wider use.
Health Rounds: Weight-loss surgery more effective than drugs in real world study
Clinical trials show weight loss between 15% to 21% for GLP-1s, but this study suggests that weight loss in the real world is considerably lower even for patients who have active prescriptions for an entire year,
Which is more effective for weight loss, GLP-1 drugs or surgery? new study has answer
GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it down.
Tyla18h
Everything that happens to your body after you stop taking Mounjaro for weight-loss
The side effects of taking Mounjaro can be very varied, and the drug tends to affect people differently. The most common side effects include feeling sick, diarrhoea, constipation, vomiting, heartburn ...
Newsday13d
Weight loss drugs, like Ozempic and Wegovy, are changing lives on Long Island — but at a crushing cost for some
The drugs were originally prescribed to treat diabetes but have been proven to be highly effective for weight loss. Nearly 4 in ... Some patients, she added, may now turn to bariatric ...
Nature8d
How to keep weight off after obesity drugs
Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or ...
Business Daily Africa3d
Weight loss cost: Beyond TikTok celebrity medical endorsements
Plastic surgeon Dr Benjamin Wabwire explains the current landscape of clinical weight management and why deeper scrutiny is ...
Hyd: Lose weight to keep diabetes away: Kamineni Hospital doctors
Weight loss can significantly reduce the severity of diabetes, said Dr. Sandeep Reddy, Endocrinologist, and Dr. Bhavani, Consultant Diabetologist at Kamineni Hospitals here today.
Weight-loss drugs and pregnancy, and do ‘skinny jabs’ prevent the pill working
Ozempic, which was introduced into the UK in January 2019, having previously been approved in the US in 2017, is an ...
An experimental obesity drug shows promise in early trials
Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.
Newsable Asianet News on MSN2d
Eli Lilly To Offer Highest Doses Of Weight-Loss Medicine On Its Digital Health Platform, But Retail Wants More Good News
Healthcare providers can begin prescribing the 12.5 mg and 15 mg vials on July 7, and shipments to patients will start in early August.